Zydus Lifesciences
Pharmaceutical Manufacturing
Key Highlights
Revenue - ₹1,54,899 million (2022)
Net Profit - ₹44,873 million (2022)
About Zydus Lifesciences
After a journey of growth spanning 27 years as Cadila Healthcare Ltd. and the Zydus Group, we have evolved and transformed ourselves in response to the changing times. Our legacy of over 70 years in healthcare and being dedicated to life in all its dimensions is reaffirmed in our new mission, vision and purpose. Unifying ourselves under the Zydus name, Cadila Healthcare Ltd., is renamed as Zydus Lifesciences Ltd.
Zydus Lifesciences Limited, a leading Indian Pharmaceutical company is a fully integrated, global healthcare provider. With in-depth domain expertise in the field of healthcare, it has strong capabilities across the spectrum of the pharmaceutical value chain. From formulations to active pharmaceutical ingredients and animal healthcare products to wellness products, Zydus has earned a reputation amongst Indian pharmaceutical companies for providing comprehensive and complete healthcare solutions.
One of the salient features of Zydus is its rich history and lineage. The origin of the company dates all the way back to the 1950s. The company was founded in the year 1952 by Mr. Ramanbhai B. Patel (late), a first-generation entrepreneur and a doyen in the field of Indian Pharmaceuticals.
In 1995, the group was restructured and thus was formed Cadila Healthcare under the aegis of the Zydus group. From a humble turnover Rs. 250 crores in 1995 the group witnessed a significant financial growth and registered a turnover of over Rs. 15,000 crores in FY-21.
Adhering to its brand promise of being dedicated to life in all its dimensions, Zydus continues to innovate with an unswerving focus to address the unmet healthcare needs. Simultaneously it rededicates itself to its mission of creating healthier, happier communities across the globe.
Awards & Accolades:
- The Overall India Pharma Excellence Award and the India Pharma Innovation of the Year Award from the Department of Pharmaceuticals, Government of India.
- The CII Industrial Innovation Grand Jury Award of being the Most Innovative Company of the Year.
- Declared the most Innovative Pharmaceutical Company by Thomson Reuters.
- Amongst the top 3 finalists at the Time India Awards 2017 in the ‘Global Manufacturer for the Year’ category
- Amongst the top five companies worldwide at the FT ArcelorMittal Boldness in Business Awards 2014 in the Developing Markets category
- Declared as the ‘Emerging Company of the Year’ by the Economic Times Awards for Corporate Excellence 2010.
CSR Awards:
- Pharma Company Of The Year Award by ETHealthworld India Pharmaworld Awards 2022.
- Best Pharma leader of year award to Dr. Sharvil Patel at ETHealthworld India Pharmaworld Awards 2022.
- Excellence In CSR at ETHealthworld India Pharmaworld Awards 2022.
- 7th India Pharma and India Medical Device award by the Government of India, Department of Pharmaceuticals in the India Pharma CSR of the year category.
- IDMA Aptar innovation of the year award.
- IDMA Corporate Citizen Award, 2021.
- 8th CSR Times Award in the Corporate Healthcare Sector.
- 10th Exceed CSR Awards 2021 by Sustainable Development foundation, a unit of EKDKN.
- Great Place to Work certification for the years 2021-22 and 2022-23.
- AmbitionBox ‘Best Large Pharma Company to work for’
Sources
https://www.zyduslife.com/public/pdf/financial/quarterly/ZLL-Q4-FY22-Results.pdf
Mission
To unlock new possibilities in life sciences through quality healthcare solutions that impact lives.
Vision
Be a global life-sciences company transforming lives through pathbreaking discoveries
Culture and Values
Driven by creativity and innovation, we strive for excellence and to make a difference in the world of pharmaceuticals and healthcare.